These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9853336

  • 21. Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
    Seitz U, Neumaier B, Glatting G, Kotzerke J, Bunjes D, Reske SN.
    Eur J Nucl Med; 1999 Oct; 26(10):1265-73. PubMed ID: 10541824
    [Abstract] [Full Text] [Related]

  • 22. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
    Krause T, Reinhardt M, Nitzsche E, Moser E.
    Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
    [Abstract] [Full Text] [Related]

  • 23. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
    Choi CW, Chung JK, Lee DS, Lee MC, Chung HK, Kim BK, Koh CS.
    Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
    [Abstract] [Full Text] [Related]

  • 24. Simultaneous administration of 99Tcm-HMPAO-labelled autologous leukocytes and 111In-labelled non-specific polyclonal human immunoglobulin G in bone and joint infections.
    de Lima Ramos PA, Martin-Comin J, Bajén MT, Roca M, Ricart Y, Castell M, Mora J, Puchal R, Ramos M.
    Nucl Med Commun; 1996 Sep; 17(9):749-57. PubMed ID: 8895902
    [Abstract] [Full Text] [Related]

  • 25. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
    Korppi-Tommola ET, Kairemo KJ, Jekunen AP, Niskanen EO, Savolainen SE.
    Acta Oncol; 1996 Sep; 35(3):357-65. PubMed ID: 8679267
    [Abstract] [Full Text] [Related]

  • 26. Diabetic foot infections: scintigraphic evaluation with 99Tcm-labelled anti-granulocyte antibodies.
    Dominguez-Gadea L, Martin-Curto LM, de la Calle H, Crespo A.
    Nucl Med Commun; 1993 Mar; 14(3):212-8. PubMed ID: 8455912
    [Abstract] [Full Text] [Related]

  • 27. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS, Voliotopoulos V, Stavraka A, Vlahos L.
    Anticancer Res; 1997 Mar; 17(3B):1615-8. PubMed ID: 9179204
    [Abstract] [Full Text] [Related]

  • 28. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN, Karstens JH, Glöckner WM, Ammon J, Büll U.
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [Abstract] [Full Text] [Related]

  • 29. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z, Yüksel DA, Cetingül N, Kantar M, Ozkiliç H, Moretti JL.
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [Abstract] [Full Text] [Related]

  • 30. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.
    Lam AS, Kettle AG, O'Doherty MJ, Coakley AJ, Barrington SF, Blower PJ.
    Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790
    [Abstract] [Full Text] [Related]

  • 31. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
    Gratz S, Behr T, Herrmann A, Dresing K, Tarditi L, Franceschini R, Rhodes B, Stürmer KM, Becker W.
    Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
    Hnatowich DJ, Mardirossian G, Rusckowski M, Roy S, Bushe H, Griffin TW, Brill AB.
    Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
    [Abstract] [Full Text] [Related]

  • 33. Bone marrow scintigraphy in the diagnosis of post-traumatic avascular necrosis of bone.
    Tawn DJ, Watt I.
    Br J Radiol; 1989 Sep; 62(741):790-5. PubMed ID: 2790419
    [Abstract] [Full Text] [Related]

  • 34. [Results of bone marrow scintigraphy in hematological diseases].
    Ranner G, Fueger GF, Hörmann M.
    Rofo; 1987 Mar; 146(3):300-5. PubMed ID: 3031761
    [Abstract] [Full Text] [Related]

  • 35. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
    Duncker CM, Carrió I, Berná L, Estorch M, Alonso C, Ojeda B, Blanco R, Germá JR, Ortega V.
    J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
    [Abstract] [Full Text] [Related]

  • 36. Bone scan and bone biopsy in the detection of skeletal metastases.
    Ron IG, Striecker A, Lerman H, Bar-Am A, Frisch B.
    Oncol Rep; 1999 Sep; 6(1):185-8. PubMed ID: 9864425
    [Abstract] [Full Text] [Related]

  • 37. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
    Peters AM, Roddie ME, Danpure HJ, Osman S, Zacharopoulos GP, George P, Stuttle AW, Lavender JP.
    Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
    [Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of metastases of malignant melanoma imaging with 99Tcm-glutathione and 99Tcm-anti-melanoma antibody: a comparative study.
    Duman Y, Burak Z, Ercan MT, Dirlik A, Bilkay BC, Akin Y, Taner M, Bekdik CF.
    Nucl Med Commun; 1995 Nov; 16(11):927-35. PubMed ID: 8587759
    [Abstract] [Full Text] [Related]

  • 39. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection.
    Moragas M, Lomeña F, Herranz R, García A, Piera C, Muxí A, Bassa P, Catafau A, Pavía A, Setoain J.
    Nucl Med Commun; 1991 May; 12(5):417-27. PubMed ID: 2067746
    [Abstract] [Full Text] [Related]

  • 40. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M, Müller-Mattheis VG, Vosberg H, Müller-Gärtner HW.
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.